Lubiprostone: a chloride channel activator.

In January 2006 the Food and Drug Administration approved lubiprostone for the treatment of chronic constipation in men and women aged 18 and over. Lubiprostone is categorized as a prostone, a bicyclic fatty acid metabolite of prostaglandin E1. Lubiprostone activates a specific chloride channel (ClC-2) in the gastrointestinal (GI) tract to enhance intestinal fluid secretion, which increases GI transit and improves symptoms of constipation. This article reviews the role of chloride channels in the GI tract, describes the structure, function, and pharmacokinetics of lubiprostone, and discusses clinically important data on this new medication.

[1]  B. Lacy,et al.  Gastrointestinal Motility Disorders: An Update , 2006, Digestive Diseases.

[2]  Livia Puljak,et al.  Emerging roles of chloride channels in human diseases. , 2006, Biochimica et biophysica acta.

[3]  M. Delvaux,et al.  Applied principles of neurogastroenterology: physiology/motility sensation. , 2006, Gastroenterology.

[4]  T. Iwamoto,et al.  Diversity of Cl− Channels , 2005, Cellular and Molecular Life Sciences.

[5]  T. Jentsch,et al.  CLC chloride channels and transporters , 2005, Current Opinion in Neurobiology.

[6]  C. Figueroa,et al.  ClC-2 in guinea pig colon: mRNA, immunolabeling, and functional evidence for surface epithelium localization. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[7]  Annick Thomas,et al.  Distribution of ClC-2 chloride channel in rat and human epithelial tissues. , 2002, American journal of physiology. Cell physiology.

[8]  G. Cutting,et al.  Expression of the Voltage-Gated Chloride Channel ClC-2 in Rod Bipolar Cells of the Rat Retina , 1999, The Journal of Neuroscience.

[9]  J. Barone.  Domperidone: A Peripherally Acting Dopamine2-Receptor Antagonist , 1999, The Annals of pharmacotherapy.

[10]  J. Grider,et al.  Distinct populations of sensory neurons mediate the peristaltic reflex elicited by muscle stretch and mucosal stimulation , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  Tsung-Yu Chen,et al.  Structure and function of clc channels. , 2005, Annual review of physiology.

[12]  T. Jentsch,et al.  Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models. , 2005, Annual review of physiology.

[13]  B. Lacy,et al.  Tegaserod: a new 5-HT4 agonist. , 2002, Journal of clinical gastroenterology.

[14]  K. Kunzelmann.  The cystic fibrosis transmembrane conductance regulator and its function in epithelial transport. , 1999, Reviews of physiology, biochemistry and pharmacology.